TCF25 as a Nutrient Sensor: Insights into Lysosomal Regulation During Glucose Starvation

Study Background and Research Question

Cellular adaptation to nutrient deprivation is a central theme in metabolic biology. Glucose, as the primary carbon source, is required for ATP production and biosynthetic processes. When glucose becomes limited, cells engage various compensatory mechanisms such as autophagy, AMPK activation, and metabolic reprogramming to maintain energy homeostasis. However, the transition from adaptation to cell death during prolonged glucose starvation, and the molecular players orchestrating this switch, remain incompletely understood. The recent study by Ren et al. (Cell Reports, 2025) addresses this gap by investigating the role of the transcription factor TCF25 in modulating lysosomal function under nutrient stress.

Key Innovation from the Reference Study

The central innovation of Ren et al.'s work is the identification of TCF25 as a key nutrient sensor that regulates lysosomal acidification and cell death during glucose deprivation. Through a genome-wide CRISPR-Cas9 screen, TCF25 emerged as a critical determinant of cell fate in response to low-glucose conditions. The study reveals that TCF25 enhances the acidification of lysosomes via upregulation of V-ATPase components, thereby promoting autophagic flux and energy maintenance during early starvation. However, with sustained glucose deprivation, this same pathway drives ferritinophagy—a selective form of autophagy targeting ferritin—culminating in increased lysosomal membrane permeability (LMP) and lysosome-dependent cell death (LDCD). This dual role underscores the complexity of cellular responses to metabolic stress.

Methods and Experimental Design Insights

Ren et al. utilized a combination of unbiased and targeted approaches to dissect nutrient stress responses. Key experimental features include:

• Genome-wide CRISPR-Cas9 Screen: To systematically identify genes mediating glucose-starvation-induced cell death, a CRISPR screen was performed in cultured mammalian cells exposed to glucose deprivation.
• Functional Validation of TCF25: Loss- and gain-of-function studies (knockout/overexpression) established the necessity and sufficiency of TCF25 for starvation-induced cell death.
• Lysosomal Function Assays: Lysosomal pH and V-ATPase activity were measured using fluorescent probes and immunoblotting to confirm TCF25's effect on acidification.
• Ferritinophagy and LMP Analysis: The study employed ferritin degradation assays, lysosomal permeability markers, and cell viability readouts to connect TCF25 activity with autophagy-mediated cell death.
• In Vivo Relevance: The role of TCF25 was tested in a mouse model of hepatic ischemia-reperfusion injury, linking nutrient sensing to tissue injury outcomes.

Core Findings and Why They Matter

The major findings of this study can be summarized as follows:

• TCF25 is crucial for cell death under glucose starvation: Cells deficient in TCF25 exhibit increased survival, highlighting its role as a pro-death factor during metabolic stress (Ren et al., 2025).
• TCF25 promotes lysosomal acidification via V-ATPase: TCF25 directly or indirectly upregulates V-ATPase components, ensuring the maintenance of acidic lysosomal pH necessary for autophagic activity.
• Prolonged TCF25 activity triggers ferritinophagy and LMP: Sustained glucose deprivation leads to excessive ferritin degradation, iron release, and increased lysosomal membrane permeability, ultimately resulting in cell death.
• Protection from tissue injury in TCF25-deficient mice: Genetic ablation of TCF25 confers resistance to hepatic ischemia-reperfusion injury, linking these molecular events to pathological outcomes.

These insights suggest that TCF25 serves as a molecular switch controlling the balance between adaptation and cell death under nutrient stress. Targeting this pathway could offer new therapeutic strategies for diseases associated with metabolic dysregulation and ischemic injury.

Comparison with Existing Internal Articles and Implications for Iron Chelation

While Ren et al. focus on the role of TCF25 in lysosomal cell death and ferritinophagy, there is a compelling intersection with research on iron metabolism and its modulation in disease. Internal articles such as "Deferasirox: Oral Iron Chelator Advancing Cancer Research" highlight how manipulation of iron availability—particularly with oral iron chelators like Deferasirox—can influence cellular stress responses, apoptosis, and tumor growth. Both ferritinophagy and iron chelation converge on the regulation of intracellular iron pools and oxidative stress.

Deferasirox, as detailed in internal reviews, has demonstrated utility in inhibiting iron uptake from transferrin and inducing apoptosis via caspase-3 activation in cancer models. The mechanistic overlap with TCF25-driven ferritinophagy raises intriguing possibilities for targeting iron metabolism to modulate cell death pathways. However, while the internal articles focus on therapeutic iron chelation and cancer, the reference study provides new mechanistic detail regarding how iron release from ferritin, mediated by lysosomal activity, can trigger cell death under metabolic stress.

Limitations and Transferability

Several considerations temper the immediate translational impact of these findings:

• Model System Specificity: The majority of experimental data were generated in cell lines and a specific mouse injury model. The generalizability of TCF25's role across different tissues or disease contexts requires further exploration.
• Therapeutic Targeting: While TCF25 appears to be a promising target for modulating cell death during nutrient stress, its broader physiological functions and potential side effects of inhibition are not fully characterized.
• Iron-Chelator Interventions: Direct connections between pharmacological iron chelation (e.g., with Deferasirox) and TCF25-mediated pathways are not established in this study, though mechanistic parallels invite further research.

Protocol Parameters

• Glucose starvation induction: Remove glucose from standard culture medium; monitor cell viability at 12-48 h intervals.
• TCF25 knockout/overexpression: Employ CRISPR-Cas9 for gene editing or lentiviral vectors for overexpression; verify efficiency by qPCR and immunoblot.
• Lysosomal acidification assay: Use LysoTracker or pH-sensitive fluorescent probes; quantify by flow cytometry or fluorescence microscopy.
• Ferritinophagy assessment: Track ferritin protein degradation via Western blotting; assess lysosomal membrane permeability using galectin puncta formation or acridine orange relocation.

Research Support Resources

Researchers interested in modulating iron metabolism or investigating lysosomal pathways under nutrient stress may benefit from integrating iron chelators into their workflows. Deferasirox (SKU A8639) is a well-characterized oral iron chelator with established use in both iron overload and cancer research models. Its capacity to bind trivalent iron and modulate oxidative stress responses makes it suitable for studies examining iron-dependent cell death pathways, as discussed in the context of nutrient sensing and stress adaptation. For experimental details, refer to the product information and relevant literature. When using Deferasirox, standard in vitro concentrations range from 3 to 20 μM, and solutions should be freshly prepared due to limited long-term stability.